<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In recent years an increase of functional CD4(+)CD25(+) regulatory T cells (T(reg) cells) has been established for patients with <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, <z:hpo ids='HP_0002488'>acute leukemias</z:hpo>, and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We have reported an expanded pool of CD4(+)CD25(high) T(reg) cells in patients with <z:hpo ids='HP_0005550'>chronic lymphatic leukemia</z:hpo> (CLL), <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) as well as its premalignant precursor <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of undetermined significance</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>In healthy individuals, low-level expression of CD127 on T cells in addition to the expression of FOXP3 has been associated with T(reg) cells </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we demonstrate that the expanded FOXP3(+) T-cell population in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, CLL, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e>, MM, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> are exclusively CD127(low) T(reg) cells and were strongly suppressive </plain></SENT>
<SENT sid="4" pm="."><plain>A significant portion of CD127(low)FOXP3(+) T(reg) cells expressed only low levels of CD25 suggesting that the previously reported expansion of CD25(+) T(reg) cells underestimates the true expansion </plain></SENT>
<SENT sid="5" pm="."><plain>The assessment of CCR7 and CD45RA expression on the expanded CD4(+)CD127(low)FOXP3(+) T(reg) cells revealed an increase of both na√Øve as well as central and effector memory T(reg) cells in peripheral blood </plain></SENT>
<SENT sid="6" pm="."><plain>Our data strongly support superiority of combined CD127 and FOXP3 analysis in comparison to CD25 and FOXP3 assessment for further quantification of T(reg) cells in malignant diseases </plain></SENT>
</text></document>